WHWK Stock Analysis: Buy, Sell, or Hold?
WHWK - Whitehawk Therapeutics, Inc. Common Stock
$3.26
0.10 (3.16%)
▲
5d:
-10.68%
30d:
-7.12%
90d:
+22.1%
WAIT
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When WHWK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: WHWK is down 10.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: WHWK is down 10.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: WHWK is currently trading at $3.26, which is considered slightly low relative to its 30-day fair value range of $3.21 to $3.86.
Technical Outlook: Technically, WHWK is in a strong uptrend. Immediate support is located at $3.15, while resistance sits at $3.99. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $5.67 (+79.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, WHWK is in a strong uptrend. Immediate support is located at $3.15, while resistance sits at $3.99. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $5.67 (+79.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$3.21 -
$3.86
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
90.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.2%)
- BULLISH: Trading 79.3% below Wall St target ($5.67)
- WARNING: Recommendation downgraded due to -10.7% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$3.21 -
$3.86
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$0.49
(15.1%)
Support & Resistance Levels
Support Level
$3.15
Resistance Level
$3.99
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.63
Wall Street Target
$5.67
(+79.3%)
Revenue Growth (YoY)
-100.0%
Profit Margin
-288.3%
Share & Embed Analysis
Last updated: March 30, 2026 1:58 PM ET
Data refreshes hourly during market hours. Next update: 2:58 PM
Data refreshes hourly during market hours. Next update: 2:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WHWK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Bryan Ball
SELL
1834 shares
2026-03-02
David James Lennon
SELL
5100 shares
2026-03-02
Scott M Giacobello
SELL
2594 shares
2026-03-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 52 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 48 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 67 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 48 HOLD |